Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells

Panagiotis Karagiannis(Guy's Hospital), Josef Singer(Medical University of Vienna), James Hunt(King's College London), Samuel Ken‐En Gan(King's College London), Sarah Maria Rudman(King's College London), Diana Mechtcheriakova(Medical University of Vienna), Regina Knittelfelder(Medical University of Vienna), Tracy R. Daniels‐Wells(University of California, Los Angeles), Philip Hobson(King's College London), Andrew J. Beavil(King's College London), James Spicer(King's College London), Frank O. Nestlé(Guy's Hospital), Manuel L. Penichet(University of California, Los Angeles), Hannah J. Gould(King's College London), Erika Jensen‐Jarolim(Medical University of Vienna), Sophia N. Karagiannis(King's College London)
Cancer Immunology Immunotherapy
October 21, 2008
Cited by 105Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis